Norbrook® Launches New Firox™ (firocoxib) Chewable Tablets, Providing Veterinarians and Dog Owners an Effective, Affordable and Convenient Non-steroidal Anti-inflammatory Drug (NSAID) option.
Lenexa, KS December 16, 2022 – Norbrook Inc., dedicated to providing quality veterinary pharmaceuticals at an affordable price, today announced it has released Firox™ (firocoxib) Chewable Tablets. The new tablets are a coxib class NSAID indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopaedic surgery in dogs. They have the same safety, efficacy and indications as the pioneer, but they are much more affordable, allowing veterinarians to pass some of that savings on to their clients, while also boosting their profits. Firox Chewable Tablets will be a welcome complement to Norbrook’s current companion animal NSAID portfolio which includes Carprieve® (carprofen) Caplets, Chewable Tablets, and Injection for dogs as well as Loxicom® Oral suspension for dogs, and Loxicom® Injection for cats and dogs.
“In today’s economic climate, veterinary clinics and their clients are facing immense pressure to provide the best quality treatment for pets, while also having to closely manage their budgets,” says Dr. Scott Krick, Technical Service Veterinarian, Norbrook. “At Norbrook, we don’t want anyone to have to choose between the two. Now, with the expanded NSAID portfolio, they don’t have to. Pets can get the effective and flexible treatment they need, clients get an affordable option, and clinics get a boost to their bottom line.”
Indications Firox™ Chewable Tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopaedic surgery in dogs.
Dosing Made Easy Firox Chewable Tablets make dosing easy for both veterinarians and dog owning clients. Available in 57 and 227 mg strengths, in both 60 and economical, 180 count bottles, the liver-flavored tablets are scored, making them easy for clients to break, and convenient to administer.
Affordability While bioequivalent to Previcox® (firocoxib) Chewable Tablets, Firox Chewable Tablets are more affordable. Veterinarians can save up to 25% percent when choosing Firox Chewable Tablets over the pioneer product, allowing them to pass some of the savings on to clients while increasing practice profitability.
©2022. All rights reserved. Norbrook is a registered trademark and Firox is a trademark of Norbrook Laboratories Limited. Previcox is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.
Established in 1969, Norbrook is one of world’s largest manufacturers of veterinary sterile injectables as well as companion animal and livestock private-label brands in the U.S. Norbrook manufacturers many of its own active pharmaceutical ingredients (APIs), ensuring quality and control over costs. With over 50 years of experience delivering trusted, quality brands for its customers, it continues to drive the business forward by reinvesting in its infrastructure and new product development. For more information about Norbrook brands, visit www.norbrook.com.
For further information please contact our US office here.